[Current aspects of recovery and invalidism in recurrent pulmonary tuberculosis].
An analysis was made, 12 months after strictly supervised treatment which included rifampicin and/or etambutol, of 83 cases of relapses of pulmonary tuberculosis. Therapeutic aspects were studied, as well as problems in relation to the possibility to continue work, as well as temporary invalidity. The therapeutic curing of the relapses was achieved in 74 patients (89,15 percent), while 9 remained with a positive bK in the sputum. The recovered subjects continued their activity without any changes in the working place, and retirement was accepted for active tuberculosis in 12,5 percent of the patients, while retirement for posttuberculous syndrome in another 7,14 percent of the patients. Males were predominant (81,81 percent of the total), mostly aged between 30 and 49 years, originating from rural environments.
D000328:Adult; D000367:Age Factors; D000368:Aged; D004185:Disability Evaluation; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009790:Occupations; D012008:Recurrence; D012293:Rifampin / Q000627:therapeutic use; D012383:Romania; D012424:Rural Population; D012737:Sex Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000534:rehabilitation*; D014505:Urban Population; D014938:Work Capacity Evaluation
D004977:Ethambutol; D012293:Rifampin
Aspecte actuale privind recuperarea şi invaliditatea în tuberculoza pulmonară recidivată.